Who Owns Cytokinetics Inc
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Cytokinetics Inc.
Who crossed 5% of CYTK →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| Mirador Capital Partners LPCOM NEW208.9K shadded | $13.8M |
| Veracity Capital LLCCOM NEW7.4K shadded | $489.1K |
| Breakwater Capital GroupCOM NEW3.9K shheld | $259.8K |
| GAMMA Investing LLCCommon Stock2.7K shadded | $178K |
| Farther Finance Advisors, LLCStock712 shadded | $46.9K |
| MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock376 shtrimmed | $24.8K |
| ELEVATION WEALTH PARTNERS, LLCCOM NEW74 shheld | $4.9K |
| Trust CoStock10 shheld | $659 |
| GILPIN WEALTH MANAGEMENT, LLCCOM NEW2 sh— | $132 |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on CYTK
Follow Cytokinetics Inc (CYTK) by email
New trades in Cytokinetics Inc (CYTK) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.